Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Sunitinib Sandoz
Active Ingredient: Sunitinib 12.5mg
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Remedica Limited, Limassol Cyprus
Pharmacare Premium Limited, Birzebbugia, Malta
   
Product: Sunitinib Sandoz
Active Ingredient: Sunitinib 25mg
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Remedica Limited, Limassol, Cyprus
Pharmacare Premium Limited, Birzebbugia, Malta
   
Product: Sunitinib Sandoz
Active Ingredient: Sunitinib 37.5mg
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Remedica Limited, Limassol, Cyprus
Pharmacare Premium Limited, Birzebbugia, Malta
   
Product: Sunitinib Sandoz
Active Ingredient: Sunitinib 50mg
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Remedica Limited, Limassol, Cyprus
Pharmacare Premium Limited, Birzebbugia, Malta
   
Product: Tacrolimus Sandoz
Active Ingredient: Tacrolimus monohydrate 0.511mg equivalent to tacrolimus 0.5mg
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Sandoz Private Limited, Navi Mumbai, India
   
Product: Tacrolimus Sandoz
Active Ingredient: Tacrolimus monohydrate 0.767mg equivalent to tacrolimus 0.75mg
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Sandoz Private Limited, Navi Mumbai, India
   
Product: Tacrolimus Sandoz
Active Ingredient: Tacrolimus monohydrate 1.022mg equivalent to tacrolimus 1mg
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Sandoz Private Limited, Navi Mumbai, India
   
Product: Tacrolimus Sandoz
Active Ingredient: Tacrolimus monohydrate 2.044mg equivalent to tacrolimus 2mg
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Sandoz Private Limited, Navi Mumbai, India
   
Product: Tacrolimus Sandoz
Active Ingredient: Tacrolimus monohydrate 5.11mg equivalent to tacrolimus 5mg
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Sandoz Private Limited, Navi Mumbai, India


Dated this 30th day of June 2023.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).